In vivo evidence for inverse agonism of agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice

Diabetes

Volumn 57, Issue 1, 2008, Pages 86-94

  Tolle, Virginie ^a,c   Low, Malcolm J ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; GHRELIN; INTERMEDIN; MELANOTAN II; PROOPIOMELANOCORTIN; ALPHA INTERMEDIN; CYCLOPEPTIDE; DRUG DERIVATIVE; MELANOTAN-II; PEPTIDE FRAGMENT; PRIMER DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR SENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BRAIN; CALORIC INTAKE; DRUG EFFECT; ENERGY METABOLISM; GENETICS; HYPERPHAGIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGOUTI-RELATED PROTEIN; ALPHA-MSH; ANIMALS; ANOREXIA; BODY WEIGHT; BRAIN; DNA PRIMERS; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; GHRELIN; HYPERPHAGIA; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, KNOCKOUT; OXYGEN CONSUMPTION; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PRO-OPIOMELANOCORTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 38449087113     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0733     Document Type: Article

References (50)

1. Challis BG, Coll AP, Yeo GS, Pinnock SB, Dickson SL, Thresher RR, Dixon J, Zahn D, Rochford JJ, White A, Oliver RL, Millington G, Aparicio SA, Colledge WH, Russ AP, Carlton MB, O'Rahilly S: Mice lacking proopiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci U S A 101:4695-4700, 2004
2. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157, 1998
3. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U: Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070, 1999
4. Smart JL, Tolle V, Low MJ: Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. J Clin Invest 116:495-505, 2006
5. Tung YC, Piper SJ, Yeung D, O'Rahilly S, Coll AP: A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice. Endocrinology 147:5940-5947, 2006
6. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD: A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518-3521, 2000
7. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102, 2000
8. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141, 1997
9. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168, 1997
10. McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW: Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 279:R695-R703, 2000
11. Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ: Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Physiol 274:R248-R254, 1998
12. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138, 1997
13. Pritchard LE, Armstrong D, Davies N, Oliver RL, Schmitz CA, Brennand JC, Wilkinson GF, White A: Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands. J Endocrinol 180:183-191, 2004
14. Haskell-Luevano C, Chen P, Li C, Chang K, Smith MS, Cameron JL, Cone RD: Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. Endocrinology 140:1408-1415, 1999
15. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308, 1994
16. Fekete C, Legradi G, Mihaly E, Huang QH, Tatro JB, Rand WM, Emerson CH, Lechan RM: Alpha-melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 20:1550-1558, 2000
17. Adan RA, Kas MJ: Inverse agonism gains weight. Trends Pharmacol Sci 24:315-321, 2003
18. Chai BX, Neubig RR, Millhauser GL, Thompson DA, Jackson PJ, Barsh GS, Dickinson CJ, Li JY, Lai YM, Gantz I: Inverse agonist activity of agouti and agouti-related protein. Peptides 24:603-609, 2003
19. Haskell-Luevano C, Monck EK: Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 99:1-7, 2001
20. Nijenhuis WA, Oosterom J, Adan RA: AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15:164-171, 2001
21. Srinivasan S, Lubrano-Berthelier C, Govaerts C, Picard F, Santiago P, Conklin BR, Vaisse C: Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114:1158-1164, 2004
22. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC, Seeley RJ: Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 279:R47-R52, 2000
23. Kim MS, Rossi M, Abbott CR, AlAhmed SH, Smith DM, Bloom SR: Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor. Peptides 23:1069-1076, 2002
24. Lu XY, Nicholson JR, Akil H, Watson SJ: Time course of short-term and long-term orexigenic effects of Agouti-related protein (86-132). Neuroreport 12:1281-1284, 2001
25. Kask A, Rago L, Korrovits P, Wikberg JE, Schioth HB: Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. Biochem Biophys Res Commun 248:245-249, 1998
26. Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ: Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes 52:2928-2934, 2003
27. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S: Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145:2607-2612, 2004
28. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408, 2001
29. Cettour-Rose P, Rohner-Jeanrenaud F: The leptin-like effects of 3-D peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143:2277-2283, 2002
30. Hansen MJ, Ball MJ, Morris MJ: Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892:130-137, 2001
31. Bluher S, Ziotopoulou M, Bullen JW Jr, Moschos SJ, Ungsunan L, Kokkotou E, Maratos-Flier E, Mantzoros CS: Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes 53:82-90, 2004
32. Huang XF, Han M, South T, Storlien L: Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity. Brain Res 992:9-19, 2003
33. Kim EM, O'Hare E, Grace MK, Welch CC, Billington CJ, Levine AS: ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean Zucker rats. Brain Res 862:11-16, 2000
34. Korner J, Wardlaw SL, Liu SM, Conwell IM, Leibel RL, Chua SC Jr: Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats. Endocrinology 141:2465-2471, 2000
35. Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, Seeley RJ: Immediate and prolonged patterns of Agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology 142:1050-1056, 2001
36. Coll AP, Challis BG, Lopez M, Piper S, Yeo GS, O'Rahilly S: Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 54:2269-2276, 2005
37. Chen M, Celik A, Georgeson KE, Harmon CM, Yang Y: Molecular basis of melanocortin-4 receptor for AGRP inverse agonism. Regul Pept 136:40-49, 2006
38. Breit A, Wolff K, Kalwa H, Jarry H, Buch T, Gudermann T: The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors. J Biol Chem 281:37447-37456, 2006
39. Smart JL, Tolle V, Otero-Corchon V, Low MJ: Central dysregulation of the hypothalamic-pituitary-adrenal axis in neuron-specific proopiomelanocortin- deficient mice. Endocrinology 148:647-659, 2007
40. Stanley SA, Small CJ, Murphy KG, Rayes E, Abbott CR, Seal LJ, Morgan DG, Sunter D, Dakin CL, Kim MS, Hunter R, Kuhar M, Ghatei MA, Bloom SR: Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 893:186-194, 2001
41. Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR, O'Rahilly S: The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145:4721-4727, 2004
42. Coll AP, Fassnacht M, Klammer S, Hahner S, Schulte DM, Piper S, Tung YC, Challis BG, Weinstein Y, Allolio B, O'Rahilly S, Beuschlein F: Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. J Endocrinol 190:515-525, 2006
43. Small CJ, Liu YL, Stanley SA, Connoley IP, Kennedy A, Stock MJ, Bloom SR: Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. Int J Obes Relat Metab Disord 27:530-533, 2003
44. Makimura H, Mizuno TM, Mastaitis JW, Agami R, Mobbs CV: Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci 3:18, 2002
45. Fan W, Voss-Andreae A, Cao WH, Morrison SF: Regulation of thermogenesis by the central melanocortin system. Peptides 26:1800-1813, 2005
46. Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD: Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 4:605-611, 2001
47. Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG, Marsh DJ, Forrest MJ, Gopal-Truter S, Fisher J, Camacho RE, Strack AM, Mellin TN, MacIntyre DE, Chen HY, Van der Ploeg LH: Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 9:145-154, 2000
48. Mohammad S, Baldini G, Granell S, Narducci P, Martelli AM, Baldini G: Constitutive traffic of melanocortin-4 receptor in Neuro2A cells and immortalized hypothalamic neurons. J Biol Chem 282:4963-4974, 2007
49. Peter JC, Nicholson JR, Heydet D, Lecourt AC, Hoebeke J, Hofbauer KG: Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo. Am J Physiol Regul Integr Comp Physiol 292:R2151-R2158, 2007
50. Srinivasan S, Santiago P, Lubrano C, Vaisse C, Conklin BR: Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PLoS ONE 2: e668, 2007